Meet the Researchers

Dennis Adeegbe, Ph.D.

H. Lee Moffitt Cancer Center & Research Institute

Boosting Immune Activity in the Fight Against Non-Small Cell Lung Cancer

John Albeck, Ph.D.

University of California, Davis

Learning How the Body Repairs Damaged Lung Epithelium

Mehdi Alilou, Ph.D.

Case Western Reserve University

Novel Nodule Vessel Features to Predict Response to Lung Cancer Therapies

Karim Bahmed, Ph.D.

Temple University

Protecting Alveolar Cells in Emphysema

Tishra Beeson, DrPH, MPH

Central Washington University (CWU)

Keys to Prevention: Reducing Community Spread of COVID-19 in Vulnerable Communities

Georgiana Bostean, Ph.D.

Chapman University

Leveraging policy and retail environments to reduce adolescent vaping and smoking of tobacco and cannabis products

Meredith Brooks, Ph.D.

Harvard Medical School

Geospatial signals in pediatric tuberculosis

Nunzia Caporarello, Ph.D.

Mayo Clinic

Targeting vascular rarefaction and loss of endothelial identity in pulmonary fibrosis

Stephen Chan, M.D., Ph.D.

University of Pittsburgh

NCOA7 as a novel therapeutic and genetic diagnostic target in SARS-CoV-2 infection

Jichao Chen, Ph.D.

University of Texas M.D. Anderson Cancer Center

Origin and function of a novel cell population

Limo Chen, Ph.D.

University of Texas M.D. Anderson Cancer Center

Targeting Protein to Improve Immunotherapy for Lung Cancer

Ya-Wen Chen, Ph.D.

University of Southern California

Roles of hypoxia and Wnt signaling in human progenitor cell fate decision during lung injury

Haiying Cheng, M.D, Ph.D.

Albert Einstein College of Medicine

Potential new immune evasion pathways and molecular targets in lung cancer

Simon Cheng, M.D., Ph.D.

Columbia University in the City of New York

Will Blocking Bmi1 Protein Improve Lung Cancer Immunotherapy?

Sangwoon Chung, Ph.D.

The Ohio State University

Preventing neutrophilic inflammation in severe asthma by targeting ETosis

Miranda Curtiss, M.D., Ph.D.

University of Alabama at Birmingham

CXCR5/Chi3l1 axis regulates allergic disease

Suellen D`Arc dos Santos Oliveira, Ph.D

University of Illinois at Chicago

Role of Caveolin-1 and BMPRII Short Form in Pulmonary Vascular Homeostasis

Brandon DeKosky, Ph.D.

University of Kansas Center for Research, Inc.

Molecular analysis of antibody responses associated with COVID-19 respiratory distress

Gregg Duncan, Ph.D.

University of Maryland-College Park

A New Way to Monitor Mucus in Obstructive Lung Diseases

Partha Dutta, Ph.D.

University of Pittsburgh

Stopping Endothelial Cell Death in Pulmonary Hypertension

Andrew Dylag, M.D.

University of Rochester Medical Center

Airway Disease Due To Aberrant Matrix Remodeling After Neonatal Hyperoxia

Hyungjin Eoh, D.V.M., Ph.D

University of Southern California

Drug resistance of Mycobacterium tuberculosis is enhanced by the trehalose metabolism remodeling

Andrea Frump, Ph.D.

Indiana University

Role of Protective Factor in Right Heart Failure

Marta Maria Gaglia, Ph.D.

Trustees of Tufts College (Tufts University)

Control of innate immune responses by SARS-CoV-2

Marcia Goldberg, M.D.

Massachusetts General Hospital (The General Hospital Corp.)

High resolution definition of the pathogenic immune response in ARDS during COVID-19 infection

Philip Greenberg, M.D.

Fred Hutchinson Cancer Research Center

Overcoming obstacles for cellular immunotherapy against lung cancer

Christoph Grundner, Ph.D.

Seattle Children's Hospital

Developing a Unique Dual-Action Compound to Treat Drug-Resistant TB

Andrew Haak, Ph.D.

Mayo Clinic

Catecholamine Signaling Regulates Pulmonary Fibrosis

Aaron N. Hata, M.D., Ph.D.

Massachusetts General Hospital

Exploiting potent anti-viral immunity against lung cancer through antigenic reprograming

Summer Hawkins, Ph.D.

Trustees of Boston College

How Do Tobacco and Air Pollution Policies Impact Birth Outcomes?